According to the NCI website, the anti-TIM-3 monoclonal antibody Sym023 is a recombinant, fully human monoclonal antibody against the inhibitory T-cell receptor T-cell immunoglobulin and mucin domain-containing protein 3 (TIM-3; TIM3; hepatitis A virus cellular receptor 2; HAVCR2), with potential immune checkpoint inhibitory and antineoplastic activities. Check for active clinical trials using this agent. (NCI Thesaurus)

More Information in English:

Inxight: Drugs (NIH)

AdisInsight
Link to National Cancer Institute